170 related articles for article (PubMed ID: 23129481)
1. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
[TBL] [Abstract][Full Text] [Related]
2. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk.
Cooper ML; Adami HO; Grönberg H; Wiklund F; Green FR; Rayman MP
Cancer Res; 2008 Dec; 68(24):10171-7. PubMed ID: 19074884
[TBL] [Abstract][Full Text] [Related]
3. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival.
Penney KL; Schumacher FR; Li H; Kraft P; Morris JS; Kurth T; Mucci LA; Hunter DJ; Kantoff PW; Stampfer MJ; Ma J
Cancer Prev Res (Phila); 2010 May; 3(5):604-10. PubMed ID: 20424130
[TBL] [Abstract][Full Text] [Related]
4. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
[TBL] [Abstract][Full Text] [Related]
5. Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
Outzen M; Tjønneland A; Hughes DJ; Jenab M; Frederiksen K; Schomburg L; Morris S; Overvad K; Olsen A
Int J Cancer; 2021 Feb; 148(4):876-883. PubMed ID: 32838475
[TBL] [Abstract][Full Text] [Related]
6. Selenoprotein gene variants, toenail selenium levels, and risk for advanced prostate cancer.
Geybels MS; van den Brandt PA; Schouten LJ; van Schooten FJ; van Breda SG; Rayman MP; Green FR; Verhage BA
J Natl Cancer Inst; 2014 Mar; 106(3):dju003. PubMed ID: 24563517
[TBL] [Abstract][Full Text] [Related]
7. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.
Peters U; Chatterjee N; Hayes RB; Schoen RE; Wang Y; Chanock SJ; Foster CB
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1144-54. PubMed ID: 18483336
[TBL] [Abstract][Full Text] [Related]
8. Variation in selenoenzyme genes and prostate cancer risk and survival.
Geybels MS; Hutter CM; Kwon EM; Ostrander EA; Fu R; Feng Z; Stanford JL; Peters U
Prostate; 2013 May; 73(7):734-42. PubMed ID: 23143801
[TBL] [Abstract][Full Text] [Related]
9. Correlations of SELENOF and SELENOP genotypes with serum selenium levels and prostate cancer.
Ekoue DN; Ansong E; Liu L; Macias V; Deaton R; Lacher C; Picklo M; Nonn L; Gann PH; Kajdacsy-Balla A; Prins GS; Freeman VL; Diamond AM
Prostate; 2018 Mar; 78(4):279-288. PubMed ID: 29314169
[TBL] [Abstract][Full Text] [Related]
10. Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics.
Hellwege JN; Palmer ND; Ziegler JT; Langefeld CD; Lorenzo C; Norris JM; Takamura T; Bowden DW
Gene; 2014 Jan; 534(1):33-9. PubMed ID: 24161883
[TBL] [Abstract][Full Text] [Related]
11. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men.
Steinbrecher A; Méplan C; Hesketh J; Schomburg L; Endermann T; Jansen E; Akesson B; Rohrmann S; Linseisen J
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2958-68. PubMed ID: 20852007
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
[TBL] [Abstract][Full Text] [Related]
13. Selenoprotein and antioxidant genes and the risk of high-grade prostate cancer and prostate cancer recurrence.
Gerstenberger JP; Bauer SR; Van Blarigan EL; Sosa E; Song X; Witte JS; Carroll PR; Chan JM
Prostate; 2015 Jan; 75(1):60-9. PubMed ID: 25284284
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms that affect selenium status and response to selenium supplementation in United Kingdom pregnant women.
Mao J; Vanderlelie JJ; Perkins AV; Redman CW; Ahmadi KR; Rayman MP
Am J Clin Nutr; 2016 Jan; 103(1):100-6. PubMed ID: 26675765
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking selenoprotein P and selenocysteine lyase exhibit severe neurological dysfunction, neurodegeneration, and audiogenic seizures.
Byrns CN; Pitts MW; Gilman CA; Hashimoto AC; Berry MJ
J Biol Chem; 2014 Apr; 289(14):9662-74. PubMed ID: 24519931
[TBL] [Abstract][Full Text] [Related]
16. Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Mondul AM; Lindström S; Tsilidis KK; Travis RC; Gerke T; Albanes D; Mucci LA; Giovannucci E; Kraft P;
Cancer; 2015 Jun; 121(12):1949-56. PubMed ID: 25731953
[TBL] [Abstract][Full Text] [Related]
17. Effects of selenium supplementation on expression of SEPP1 in mRNA and protein levels in subjects with and without metabolic syndrome suffering from coronary artery disease: Selenegene study a double-blind randomized controlled trial.
Gharipour M; Ouguerram K; Nazih EH; Salehi M; Behmanesh M; Roohafza H; Hosseini SM; Nezafati P; Dianatkhah M; Gharipour A; Haghjoo S; Sarrafzadegan N; Sadeghi M
J Cell Biochem; 2018 Nov; 119(10):8282-8289. PubMed ID: 29932230
[TBL] [Abstract][Full Text] [Related]
18. Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis.
Hill KE; Wu S; Motley AK; Stevenson TD; Winfrey VP; Capecchi MR; Atkins JF; Burk RF
J Biol Chem; 2012 Nov; 287(48):40414-24. PubMed ID: 23038251
[TBL] [Abstract][Full Text] [Related]
19. Interaction of NKX3.1 and SELENOP genotype with prostate cancer recurrence.
Donadio JLS; Liu L; Freeman VL; Ekoue DN; Diamond AM; Bermano G
Prostate; 2019 Apr; 79(5):462-467. PubMed ID: 30582190
[TBL] [Abstract][Full Text] [Related]
20. Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality.
Zelic R; Fiano V; Ebot EM; Coseo Markt S; Grasso C; Trevisan M; De Marco L; Delsedime L; Zugna D; Mucci LA; Richiardi L
Prostate Cancer Prostatic Dis; 2019 May; 22(2):284-291. PubMed ID: 30341411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
